[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Bioventus Inc Cl A (BVS)

Bioventus Inc Cl A (BVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,162,390
  • Shares Outstanding, K 83,535
  • Annual Sales, $ 568,090 K
  • Annual Income, $ 22,730 K
  • EBIT $ 65 M
  • EBITDA $ 112 M
  • 60-Month Beta 0.63
  • Price/Sales 2.04
  • Price/Cash Flow 10.95
  • Price/Book 4.20

Options Overview Details

View History
  • Implied Volatility 61.01% (+4.32%)
  • Historical Volatility 70.11%
  • IV Percentile 8%
  • IV Rank 10.75%
  • IV High 308.26% on 11/19/25
  • IV Low 31.23% on 09/04/25
  • Expected Move (DTE 8) 0.14 (1.04%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 5
  • Volume Avg (30-Day) 366
  • Put/Call OI Ratio 0.44
  • Today's Open Interest 5,023
  • Open Int (30-Day) 5,552
  • Expected Range 13.77 to 14.05

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $0.17
  • Number of Estimates 2
  • High Estimate $0.17
  • Low Estimate $0.17
  • Prior Year $0.15
  • Growth Rate Est. (year over year) +13.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
11.35 +21.94%
on 07/21/26
15.89 -12.92%
on 08/05/26
+1.77 (+14.66%)
since 07/13/26
3-Month
7.81 +77.21%
on 06/02/26
15.89 -12.92%
on 08/05/26
+3.44 (+33.08%)
since 05/13/26
52-Week
6.26 +121.26%
on 09/26/25
15.89 -12.92%
on 08/05/26
+6.31 (+83.80%)
since 08/13/25

Most Recent Stories

More News
Bioventus: Q2 Earnings Snapshot

Bioventus: Q2 Earnings Snapshot

BVS : 13.84 (-0.54%)
Bioventus Reports Second Quarter Financial Results

Q2 reported revenue of $153.2 million increased 4% Q2 GAAP earnings of $0.47 per diluted share compared to the prior-year period earnings of $0.11 per diluted share Non-GAAP earnings* of $0.22...

BVS : 13.84 (-0.54%)
Bioventus May Be Approaching the Limit of What Orthopedic Recovery Can Deliver

Barchart Research What to Expect from BVS Earnings BVS Generated August 4, 2026 Current Price $13.42 EPS Estimate $$0.22 Consensus Rating Strong Buy Average Move 15.51% Bioventus May Be Approaching the...

BVS : 13.84 (-0.54%)
Bioventus to Report Second Quarter of Fiscal Year 2026 Financial Results on August 5, 2026

DURHAM, N.C., July 29, 2026 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will...

BVS : 13.84 (-0.54%)
Did Bioventus Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible...

BVS : 13.84 (-0.54%)
Bioventus to Present at the Goldman Sachs 47TH Annual Global Healthcare Conference

DURHAM, N.C., June 02, 2026 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Mark Singleton, Bioventus Senior Vice-President...

BVS : 13.84 (-0.54%)
Bioventus: Q1 Earnings Snapshot

Bioventus: Q1 Earnings Snapshot

BVS : 13.84 (-0.54%)
Bioventus Reports First Quarter Financial Results

Q1 reported revenue of $132.1 million increased 7% First quarter GAAP earnings of $0.04 per diluted share compared to the prior-year period loss of $0.04 per diluted share Non-GAAP...

BVS : 13.84 (-0.54%)
Bioventus Reports Tomorrow With Peripheral Nerve Stimulation Launch Still Unproven

Barchart Research What to Expect from BVS Earnings BVS Generated May 5, 2026 Current Price $10.68 EPS Estimate $$0.09 Consensus Rating Strong Buy Average Move 18.73% Bioventus Reports Tomorrow With Peripheral...

BVS : 13.84 (-0.54%)
TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 Revenues

MALVERN, Pa., April 30, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (“TELA Bio”), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today...

AXGN : 49.67 (+2.45%)
TELA : 0.7202 (-8.84%)
ANIK : 22.03 (+3.77%)
MDXG : 4.26 (-0.47%)
ELUT : 0.8180 (+2.06%)
BVS : 13.84 (-0.54%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Bioventus Inc. delivers clinically proven, cost-effective products which help people heal quickly and safely. It includes offerings for osteoarthritis, surgical and non-surgical bone healing. Bioventus Inc. is based in DURHAM, N.C.

See More

Key Turning Points

3rd Resistance Point 14.66
2nd Resistance Point 14.34
1st Resistance Point 14.13
Last Price 13.84
1st Support Level 13.59
2nd Support Level 13.27
3rd Support Level 13.06

See More

52-Week High 15.89
Last Price 13.84
Fibonacci 61.8% 12.21
Fibonacci 50% 11.07
Fibonacci 38.2% 9.94
52-Week Low 6.26

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.